Flexion Selects First Four Programs And Gets $9 Million From Pfizer Venture Fund
This article was originally published in The Pink Sheet Daily
Executive Summary
Modeled on Lilly's Chorus unit, Flexion purports to bring candidates to proof-of-concept quicker and cheaper than a Big Pharma typically can.